• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌根除对血糖正常人群胰岛素抵抗及糖化血红蛋白水平的影响:一项前瞻性研究。

The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study.

作者信息

Dogan Zeynal, Sarikaya Murat, Ergul Bilal, Filik Levent

机构信息

Ankara Education and Research Hospital, Gastroenterology, Turkey.

出版信息

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):242-5. doi: 10.5507/bp.2014.036. Epub 2014 Jun 19.

DOI:10.5507/bp.2014.036
PMID:24993741
Abstract

BACKGROUND AND AIM

Helicobacter pylori (H. pylori) infection is reported to be associated with various extragastrointestinal conditions such as insulin resistance, diabetes mellitus and metabolic syndrome. These conditions are attributed to systemic inflammation, leptin or ghrelin changes due to H. pylori infection. Therefore, increasing trends in the management of H. pylori infection are ordered to maintain glycemic control. In this study, we evaluated the effect of H. pylori eradication on insulin resistance in patients with normal blood glucose concentrations.

METHOD

A total of 370 patients with successful eradication were included in the study. Patients with H. pylori were given triple eradication treatment. All patients with H. pylori infection were tested for fasting glucose, fasting insulin, glicated hemoglobin (HbA1c) at baseline and 6 months after eradication treatment. Also, insulin resistance was calculated using the homeostatic model assessment of insulin resistance (HOMA-IR). Body mass index was also determined as a metabolic syndrome criteria effecting insulin resistance.

RESULTS

There were significant differences in fasting glucose, fasting insulin, HbA1c, and HOMA-IR values between before treatment and after treatment(P <0.04, <0.01, <0.01, <0.01). The favorable effect of eradication was more significant in patients with BMI≥25 mg/m(2)(P<0.05).

CONCLUSION

Eradication treatment has beneficial effects on insulin resistance in patients with normal glucose concentrations.

摘要

背景与目的

据报道,幽门螺杆菌(H. pylori)感染与多种胃肠道外疾病有关,如胰岛素抵抗、糖尿病和代谢综合征。这些疾病归因于幽门螺杆菌感染引起的全身炎症、瘦素或胃饥饿素变化。因此,为维持血糖控制,幽门螺杆菌感染的治疗趋势有所增加。在本研究中,我们评估了幽门螺杆菌根除对血糖浓度正常患者胰岛素抵抗的影响。

方法

本研究共纳入370例根除成功的患者。幽门螺杆菌感染患者接受三联根除治疗。所有幽门螺杆菌感染患者在基线及根除治疗后6个月检测空腹血糖、空腹胰岛素、糖化血红蛋白(HbA1c)。此外,使用胰岛素抵抗稳态模型评估(HOMA-IR)计算胰岛素抵抗。体重指数也被确定为影响胰岛素抵抗的代谢综合征标准。

结果

治疗前与治疗后空腹血糖、空腹胰岛素、HbA1c和HOMA-IR值存在显著差异(P<0.04、<0.01、<0.01、<0.01)。根除的有益效果在体重指数≥25 mg/m²的患者中更为显著(P<0.05)。

结论

根除治疗对血糖浓度正常的患者的胰岛素抵抗有有益影响。

相似文献

1
The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study.幽门螺杆菌根除对血糖正常人群胰岛素抵抗及糖化血红蛋白水平的影响:一项前瞻性研究。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):242-5. doi: 10.5507/bp.2014.036. Epub 2014 Jun 19.
2
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients.一项随机、双盲、安慰剂对照试验,旨在评估根除幽门螺杆菌对2型糖尿病患者葡萄糖稳态的影响。
Nutr Metab Cardiovasc Dis. 2016 Oct;26(10):893-8. doi: 10.1016/j.numecd.2016.06.012. Epub 2016 Jul 1.
3
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.幽门螺杆菌根除后肠道微生物群、抗生素耐药性和代谢参数的长期变化:一项多中心、开放标签、随机试验。
Lancet Infect Dis. 2019 Oct;19(10):1109-1120. doi: 10.1016/S1473-3099(19)30272-5.
4
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.幽门螺杆菌感染根除后消化性溃疡和胃炎患者血浆胃饥饿素和瘦素水平的变化
BMC Gastroenterol. 2016 Oct 4;16(1):119. doi: 10.1186/s12876-016-0532-2.
5
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.三联疗法与双重疗法根除幽门螺杆菌及预防溃疡复发的比较:一项关于兰索拉唑、克拉霉素和/或阿莫西林不同给药方案的随机、双盲、多中心研究。
Am J Gastroenterol. 1998 Apr;93(4):584-90. doi: 10.1111/j.1572-0241.1998.169_b.x.
6
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.近期基于泮托拉唑或兰索拉唑的克拉霉素联合阿莫西林治疗根除幽门螺杆菌取得成功。
Turk J Gastroenterol. 2004 Dec;15(4):219-24.
7
Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.10 天高剂量质子泵抑制剂三联疗法与序贯疗法根除幽门螺杆菌的比较。
J Gastroenterol Hepatol. 2018 Nov;33(11):1822-1828. doi: 10.1111/jgh.14292. Epub 2018 Jun 27.
8
The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.慢性肾功能不全患者根除幽门螺杆菌的三联疗法选择
Aliment Pharmacol Ther. 2003 May 15;17(10):1283-90. doi: 10.1046/j.1365-2036.2003.01527.x.
9
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.在日本消化性溃疡患者中,使用兰索拉唑、阿莫西林和克拉霉素三联疗法根除幽门螺杆菌的大规模多中心双盲研究的随访调查。
J Gastroenterol. 2003;38(4):339-47. doi: 10.1007/s005350300061.
10
Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.幽门螺杆菌耐药性对基于兰索拉唑的1周三联疗法疗效的影响。
J Formos Med Assoc. 2000 Sep;99(9):704-9.

引用本文的文献

1
From helicobacter pylori to glucose metabolism: can DOB values serve as a predictive marker?从幽门螺杆菌到葡萄糖代谢:尿素呼气试验值能否作为预测标志物?
Front Med (Lausanne). 2025 Aug 13;12:1612456. doi: 10.3389/fmed.2025.1612456. eCollection 2025.
2
Liubao Tea Extract Attenuates High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes in Mice by Remodeling Hepatic Metabolism and Gut Microbiota.六堡茶提取物通过重塑肝脏代谢和肠道微生物群减轻高脂饮食和链脲佐菌素诱导的小鼠2型糖尿病。
Nutrients. 2025 Aug 18;17(16):2665. doi: 10.3390/nu17162665.
3
Effect of Helicobacter pylori eradication on metabolic profile: an international, multicenter, case-control study.
幽门螺杆菌根除对代谢谱的影响:一项国际多中心病例对照研究。
BMC Gastroenterol. 2022 Dec 8;22(1):507. doi: 10.1186/s12876-022-02604-3.
4
Long-term effect of the eradication of Helicobacter pylori on the hemoglobin A1c in type 2 diabetes or prediabetes patients.根除幽门螺杆菌对 2 型糖尿病或糖尿病前期患者血红蛋白 A1c 的长期影响。
Korean J Intern Med. 2022 May;37(3):579-590. doi: 10.3904/kjim.2021.194. Epub 2022 Jan 7.
5
increases the risk of carotid plaque formation: a clinical evidence.增加颈动脉斑块形成的风险:临床证据。
Ann Med. 2021 Dec;53(1):1448-1454. doi: 10.1080/07853890.2021.1927169.
6
Gut Microbiota: The Missing Link Between Infection and Metabolic Disorders?肠道微生物群:感染和代谢紊乱之间缺失的一环?
Front Endocrinol (Lausanne). 2021 Jun 17;12:639856. doi: 10.3389/fendo.2021.639856. eCollection 2021.
7
Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.幽门螺杆菌感染可能通过促进肝功能损伤、糖代谢、脂代谢、炎症反应和代谢综合征来加重非酒精性脂肪性肝病的严重程度。
Eur J Gastroenterol Hepatol. 2020 Jul;32(7):857-866. doi: 10.1097/MEG.0000000000001601.
8
H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota.抗生素治疗根除 H. pylori 会引起与肠道微生物群改变相关的葡萄糖内稳态变化。
PLoS One. 2019 Mar 14;14(3):e0213548. doi: 10.1371/journal.pone.0213548. eCollection 2019.
9
Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes.25-羟基维生素D对2型糖尿病患者幽门螺杆菌根除的影响
Wien Klin Wochenschr. 2019 Feb;131(3-4):75-80. doi: 10.1007/s00508-018-1416-y. Epub 2018 Dec 12.
10
4-Hydroxynonenal in Redox Homeostasis of Gastrointestinal Mucosa: Implications for the Stomach in Health and Diseases.4-羟基壬烯醛在胃肠道黏膜氧化还原稳态中的作用:对胃健康与疾病的影响
Antioxidants (Basel). 2018 Sep 3;7(9):118. doi: 10.3390/antiox7090118.